Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation
Identifieur interne : 001A95 ( Main/Exploration ); précédent : 001A94; suivant : 001A96Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation
Auteurs : S. Bostantjopoulou [Grèce] ; Z. Katsarou [Grèce] ; A. Papadimitriou [Grèce] ; V. Veletza [Grèce] ; G. Hatzigeorgiou [Grèce] ; A. Lees [Royaume-Uni]Source :
- Movement Disorders [ 0885-3185 ] ; 2001-11.
English descriptors
- KwdEn :
Abstract
The motor and neuropsychological abnormalities in eight Greek patients with Parkinson's disease (PD) carrying the α‐synuclein gene mutation (G209A) were studied. These patients (five men, three women) belonged to six different families. Their symptoms started between 32–50 years of age (mean ± SD, 39.7 ± 7.6 years) and they had a mean disease duration of 5.4 ± 2.1 years (range, 2–9 years) at the time of examination. Rigidity and bradykinesia predominated both at disease onset as well as in the later stages and rest tremor was relatively uncommon. Neuropsychological assessment showed that one patient was mildly demented while another had impairment in memory, visuoconstructive abilities, and executive function. Depression was present in only one patient. Our findings indicate that genetic forms of parkinsonism share common motor and cognitive characteristics with sporadic PD but raise the possibility that greater cognitive impairment and the relative rarity of tremor may be distinctive features worthy of further investigation. © 2001 Movement Disorder Society.
Url:
DOI: 10.1002/mds.1221
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation</title><author><name sortKey="Bostantjopoulou, S" sort="Bostantjopoulou, S" uniqKey="Bostantjopoulou S" first="S." last="Bostantjopoulou">S. Bostantjopoulou</name></author><author><name sortKey="Katsarou, Z" sort="Katsarou, Z" uniqKey="Katsarou Z" first="Z." last="Katsarou">Z. Katsarou</name></author><author><name sortKey="Papadimitriou, A" sort="Papadimitriou, A" uniqKey="Papadimitriou A" first="A." last="Papadimitriou">A. Papadimitriou</name></author><author><name sortKey="Veletza, V" sort="Veletza, V" uniqKey="Veletza V" first="V." last="Veletza">V. Veletza</name></author><author><name sortKey="Hatzigeorgiou, G" sort="Hatzigeorgiou, G" uniqKey="Hatzigeorgiou G" first="G." last="Hatzigeorgiou">G. Hatzigeorgiou</name></author><author><name sortKey="Lees, A" sort="Lees, A" uniqKey="Lees A" first="A." last="Lees">A. Lees</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E4F46A9904D8235E514099949B9885803F2D2A19</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1002/mds.1221</idno><idno type="url">https://api.istex.fr/document/E4F46A9904D8235E514099949B9885803F2D2A19/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001393</idno><idno type="wicri:Area/Main/Curation">001181</idno><idno type="wicri:Area/Main/Exploration">001A95</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation</title><author><name sortKey="Bostantjopoulou, S" sort="Bostantjopoulou, S" uniqKey="Bostantjopoulou S" first="S." last="Bostantjopoulou">S. Bostantjopoulou</name><affiliation wicri:level="1"><country xml:lang="fr">Grèce</country><wicri:regionArea>3rd University Dept. of Neurology, G. Papanikolaou Hospital, Thessaloniki</wicri:regionArea><wicri:noRegion>Thessaloniki</wicri:noRegion></affiliation></author><author><name sortKey="Katsarou, Z" sort="Katsarou, Z" uniqKey="Katsarou Z" first="Z." last="Katsarou">Z. Katsarou</name><affiliation wicri:level="1"><country xml:lang="fr">Grèce</country><wicri:regionArea>3rd University Dept. of Neurology, G. Papanikolaou Hospital, Thessaloniki</wicri:regionArea><wicri:noRegion>Thessaloniki</wicri:noRegion></affiliation></author><author><name sortKey="Papadimitriou, A" sort="Papadimitriou, A" uniqKey="Papadimitriou A" first="A." last="Papadimitriou">A. Papadimitriou</name><affiliation wicri:level="1"><country xml:lang="fr">Grèce</country><wicri:regionArea>University Dept. of Neurology, Larisa</wicri:regionArea><wicri:noRegion>Larisa</wicri:noRegion></affiliation></author><author><name sortKey="Veletza, V" sort="Veletza, V" uniqKey="Veletza V" first="V." last="Veletza">V. Veletza</name><affiliation wicri:level="1"><country xml:lang="fr">Grèce</country><wicri:regionArea>University Dept. of Neurology, Larisa</wicri:regionArea><wicri:noRegion>Larisa</wicri:noRegion></affiliation></author><author><name sortKey="Hatzigeorgiou, G" sort="Hatzigeorgiou, G" uniqKey="Hatzigeorgiou G" first="G." last="Hatzigeorgiou">G. Hatzigeorgiou</name><affiliation wicri:level="1"><country xml:lang="fr">Grèce</country><wicri:regionArea>University Dept. of Neurology, Larisa</wicri:regionArea><wicri:noRegion>Larisa</wicri:noRegion></affiliation></author><author><name sortKey="Lees, A" sort="Lees, A" uniqKey="Lees A" first="A." last="Lees">A. Lees</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Reta Lila Weston Institute of Neurological Studies, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="2001-11">2001-11</date><biblScope unit="volume">16</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="1007">1007</biblScope><biblScope unit="page" to="1013">1013</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">E4F46A9904D8235E514099949B9885803F2D2A19</idno><idno type="DOI">10.1002/mds.1221</idno><idno type="ArticleID">MDS1221</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>G209A mutation</term><term>familial parkinsonism</term><term>α‐synuclein</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The motor and neuropsychological abnormalities in eight Greek patients with Parkinson's disease (PD) carrying the α‐synuclein gene mutation (G209A) were studied. These patients (five men, three women) belonged to six different families. Their symptoms started between 32–50 years of age (mean ± SD, 39.7 ± 7.6 years) and they had a mean disease duration of 5.4 ± 2.1 years (range, 2–9 years) at the time of examination. Rigidity and bradykinesia predominated both at disease onset as well as in the later stages and rest tremor was relatively uncommon. Neuropsychological assessment showed that one patient was mildly demented while another had impairment in memory, visuoconstructive abilities, and executive function. Depression was present in only one patient. Our findings indicate that genetic forms of parkinsonism share common motor and cognitive characteristics with sporadic PD but raise the possibility that greater cognitive impairment and the relative rarity of tremor may be distinctive features worthy of further investigation. © 2001 Movement Disorder Society.</div></front></TEI><affiliations><list><country><li>Grèce</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Grand Londres</li></region><settlement><li>Londres</li></settlement></list><tree><country name="Grèce"><noRegion><name sortKey="Bostantjopoulou, S" sort="Bostantjopoulou, S" uniqKey="Bostantjopoulou S" first="S." last="Bostantjopoulou">S. Bostantjopoulou</name></noRegion><name sortKey="Hatzigeorgiou, G" sort="Hatzigeorgiou, G" uniqKey="Hatzigeorgiou G" first="G." last="Hatzigeorgiou">G. Hatzigeorgiou</name><name sortKey="Katsarou, Z" sort="Katsarou, Z" uniqKey="Katsarou Z" first="Z." last="Katsarou">Z. Katsarou</name><name sortKey="Papadimitriou, A" sort="Papadimitriou, A" uniqKey="Papadimitriou A" first="A." last="Papadimitriou">A. Papadimitriou</name><name sortKey="Veletza, V" sort="Veletza, V" uniqKey="Veletza V" first="V." last="Veletza">V. Veletza</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Lees, A" sort="Lees, A" uniqKey="Lees A" first="A." last="Lees">A. Lees</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A95 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001A95 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:E4F46A9904D8235E514099949B9885803F2D2A19
|texte= Clinical features of parkinsonian patients with the α‐synuclein (G209A) mutation
}}
| This area was generated with Dilib version V0.6.23. |  |